LifeCell Corporation is now Allergan

STRATTICE™ Reconstructive Tissue Matrix

STRATTICE™ Reconstructive Tissue Matrix: The Most Clinically-Studied Biological Matrix*

What differentiates STRATTICE™ Reconstructive Tissue Matrix (RTM) from competitors is our proprietary processing method, which retains biochemical components and collagen structure to support regeneration.**1,2

* Searches performed on PubMed, Google, Google Scholar and ScienceDirect® in June 2016.
** Correlation of these results to results in humans is not established.

  1. Connor J, McQuillan D, Sandor M, et al. Retention of structural and biochemical integrity in a biological mesh supports tissue remodeling in a primate abdominal wall model. Regen Med. 2009;4(2):185-195.
  2. Sun WQ, Xu H, Sandor M, Lombardi J. Process-induced extracellular matrix alterations affect the mechanisms of soft tissue repair and regeneration. Journal of Tissue Engineering. 2013;4.
  3. Chen R, et al. Process development of an acellular dermal matrix (ADM) for biomedical applications. Biomaterials. 2004 Jun; 25(13):2679-86.
  4. Rubin Ms, et al. Parastomal hernia: is stomal relocation superior to fascial repair? Arch Surg. 1994;129:413-419.
  5. Rutkow, I.M. Demographic and Socieconomic Aspects of Hernia Repair in the United States in 2003. Surgical Clinics of North America; 83(5):1045-51, v-vi.
  6. Bellows C, et al. Prospective, Randomized, Multicenter Study of Porcine-Derived Acellular Dermal Matrix (StratticeTM) in the Repair of Inguinal Hernias (RING): Month 24 Update. Displayed at: American Hernia Society; Mar 13 – 16, 2013, Orlando, Florida, USA.